300 mg/day phenylbutazone , 210 mg/day indomethacin , and 600 mg/day pyrasanone were administered for 14 days to three randomised groups of patients respectively , consisting of a total of 76 subjects with various forms of non-infectious inflammation ( osteoarthritis , fibrositis , rheumatoid arthritis , gout , phlebitis ) , in a double-blind trila designed to determine the activity of the three drugs and their tolerance .
C0021246
indomethacin
C0029408
osteoarthritis